The journey from laboratory innovation to bedside care requires rigorous validation, regulatory clearance, and scalable production. Translational and clinical applications in regenerative medicine emphasize how preclinical successes evolve into clinically viable therapies. It involves refining delivery systems, validating efficacy in human models, and aligning treatments with patient-specific needs. Technologies like 3D-printed grafts, cell-based therapies, and gene-modified tissues are now being tested in controlled trials. Translational and clinical applications also address manufacturing challenges, ethical oversight, and physician training to ensure successful implementation. As more therapies reach early-phase and advanced clinical stages, the path to accessible and reliable regenerative solutions is becoming clearer and more standardized globally.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Planar microorganoPit-based co-culture platform (MICA) for studying tumor-immune interactions in patient-derived tumoroids
Xiaochun Cao Ehlker, HTCR-Services GmbH, Martinsried/Planegg, Germany
Title : Comparing the effect of using calcified autogenous nano dentin particles versus micro dentin particles in the healing of mandibular bony defects in New Zealand rabbits
Sarah Yasser, Oral Biology Department, Faculty of Dentistry, Tanta University, Egypt
Title : Channel fidelity limits in in-wound hydrogel printing for cartilage regeneration
Evgenia Papadimitriou, AVT.CVT, RWTH University, Germany
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom